Lyrica CR (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the Lyrica CR drug offered from Parke-Davis Div of Pfizer Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
| NON-PROPRIETARY NAME: | PREGABALIN |
| SUBSTANCE NAME: | PREGABALIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-01-01 |
| END MARKETING DATE: | 0000-00-00 |
Lyrica CR HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lyrica CR from Parke-Davis Div of Pfizer Inc |
| LABELER NAME: | Parke-Davis Div of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 165(mg/1) |
| START MARKETING DATE: | 2016-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0071-1027_baef57a9-34f3-40a5-831f-d71c195f2439 |
| PRODUCT NDC: | 0071-1027 |
| APPLICATION NUMBER: | NDA021446 |
Other PREGABALIN Pharmaceutical Manufacturers / Labelers:
